Ethics, Equity & Informed Consent

IRB/IEC Documentation for Inspection Readiness and TMF Quality

November 14, 2025November 14, 2025 digi

IRB/IEC Documentation for Inspection Readiness and TMF Quality Ensuring compliance and quality in clinical trials is a multifaceted process, critical for the integrity of data and the overall success of the trial. This article provides a comprehensive step-by-step guide for clinical operations, regulatory affairs, and medical affairs professionals focusing on Institutional Review Board (IRB) and…

IRB/IEC Submission & Continuing Review

Continuing Review in High-Risk and Vulnerable Population Studies

November 14, 2025November 14, 2025 digi

Continuing Review in High-Risk and Vulnerable Population Studies Continuing review processes are crucial for maintaining ethical standards and regulatory compliance in clinical trials, especially when studies involve high-risk and vulnerable populations. The importance of systematic monitoring through methodologies such as remote monitoring in clinical trials is gaining traction, and this article aims to provide a…

IRB/IEC Submission & Continuing Review

Sponsor Oversight of Site-Level IRB/IEC Compliance: Roles and Metrics

November 14, 2025November 14, 2025 digi

Sponsor Oversight of Site-Level IRB/IEC Compliance: Roles and Metrics Sponsor Oversight of Site-Level IRB/IEC Compliance: Roles and Metrics In the complex landscape of clinical research, ensuring that sites adhere to ethical standards monitored by Institutional Review Boards (IRBs) and Independent Ethics Committees (IECs) is paramount. This comprehensive guide provides a step-by-step approach for clinical operations,…

IRB/IEC Submission & Continuing Review

Central vs Local IRB Models: Operational Pros and Cons for Sponsors and CROs

November 14, 2025November 14, 2025 digi

Central vs Local IRB Models: Operational Pros and Cons for Sponsors and CROs In the field of clinical research, understanding the operational frameworks in which studies are conducted is essential for compliance with regulatory guidelines and ethical standards. One significant aspect of this is the choice between Central and Local Institutional Review Board (IRB) models….

IRB/IEC Submission & Continuing Review

IRB/IEC Meeting Preparation: FAQs, Investigator Obligations and Documentation

November 14, 2025November 14, 2025 digi

IRB/IEC Meeting Preparation: FAQs, Investigator Obligations and Documentation IRB/IEC Meeting Preparation: FAQs, Investigator Obligations and Documentation Introduction to IRB/IEC Meetings In the realm of clinical trials, the Institutional Review Board (IRB) or Independent Ethics Committee (IEC) plays a pivotal role in safeguarding the rights and welfare of trial participants. As regulatory bodies, they ensure that…

IRB/IEC Submission & Continuing Review

Transparency Around Payments in Consent Forms and Recruitment Materials

November 14, 2025November 14, 2025 digi

Transparency Around Payments in Consent Forms and Recruitment Materials Transparency Around Payments in Consent Forms and Recruitment Materials In the evolving landscape of clinical research, transparency regarding financial compensation and reimbursements is essential for maintaining ethical standards and ensuring informed consent. This article provides a comprehensive guide regarding the ethical considerations surrounding payments in clinical…

Compensation, Reimbursement & Undue Influence

Managing Tax, Benefits and Financial Reporting Implications of Study Payments

November 14, 2025 digi

Managing Tax, Benefits and Financial Reporting Implications of Study Payments Managing Tax, Benefits and Financial Reporting Implications of Study Payments In the landscape of clinical research, understanding the tax implications, benefits, and financial reporting related to study payments is essential. This is particularly pertinent for professionals involved in world wide clinical trials, who must navigate…

Compensation, Reimbursement & Undue Influence

Auditing Participant Compensation Records for Compliance and Fairness

November 14, 2025November 14, 2025 digi

Auditing Participant Compensation Records for Compliance and Fairness Auditing Participant Compensation Records for Compliance and Fairness In the constantly evolving landscape of clinical research, ensuring compliance and fairness in participant compensation is paramount. The integrity of clinical trials, particularly those conducted at a clinical trial center, hinges on transparent and equitable compensation practices. This article…

Compensation, Reimbursement & Undue Influence

Participant Compensation in Clinical Trials: Ethics, Regulations and Local Laws

November 14, 2025November 14, 2025 digi

Participant Compensation in Clinical Trials: Ethics, Regulations and Local Laws Participant Compensation in Clinical Trials: Ethics, Regulations and Local Laws Clinical trials are fundamental to advancing medical knowledge, validating new therapies, and ensuring safety and efficacy. An important aspect of clinical trials is the ethical and regulatory handling of participant compensation. This guide provides a…

Compensation, Reimbursement & Undue Influence

Distinguishing Compensation, Reimbursement and Incentives in Study Budgets

November 14, 2025November 14, 2025 digi

Distinguishing Compensation, Reimbursement and Incentives in Study Budgets Distinguishing Compensation, Reimbursement and Incentives in Study Budgets In the realm of clinical trials, understanding the nuances between compensation, reimbursement, and incentives is crucial for ensuring ethical compliance and maintaining regulatory integrity. This detailed guide aims to provide clinical operations, regulatory affairs, and medical affairs professionals in…

Compensation, Reimbursement & Undue Influence